VTVT Crosses Above Average Analyst Target
April 19, 2018 at 09:26 AM EDT
In recent trading, shares of vTv Therapeutics Inc (VTVT) have crossed above the average analyst 12-month target price of $2.00, changing hands for $2.20/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..